TCR-stimulated changes in cell surface CD46 expression generate type 1 regulatory T cells

Area of Science:

• Immunology
• Cell Biology
• Neuroimmunology

Background:

• Regulatory T cell dysfunction is central to autoimmune diseases like multiple sclerosis (MS).
• The complement regulatory protein CD46 normally promotes regulatory T cell differentiation, a pathway impaired in MS.
• CD46 ectodomain cleavage is essential for T cell activation.

Purpose of the Study:

• To investigate the mechanism of CD46-mediated T cell regulation.
• To understand how CD46 processing and function are altered in multiple sclerosis.

Main Methods:

• Studied CD46 molecular mass changes upon T cell receptor (TCR)-CD3 stimulation.
• Analyzed CD46 O-glycosylation and its role in T cell signaling.
• Investigated CD46 recruitment to the immune synapse.
• Compared CD46 behavior in T cells from healthy individuals and MS patients.

Main Results:

• TCR-CD3 stimulation reduced CD46 molecular mass via O-glycosylation, affecting T cell signaling.
• CD46 recruitment to the immune synapse, mediated by its STP region, shifted T cells towards IL-10 production.
• T cells from MS patients showed impaired CD3-stimulated CD46 mass reduction and increased surface CD46.

Conclusions:

• CD46's regulatory function on T cells involves O-glycosylation-dependent processing and immune synapse recruitment.
• Defective CD46 processing in MS patients may underlie impaired T cell regulation and disease pathogenesis.
• Findings offer insights into MS pathogenesis and potential targets for immunotherapy.